1027849-38-2

Basic information

• Product Name: 5-methyl-hexanoic acid 3-tert-butoxycarbonylmethyl-1-(4-chloro-benzoyl)-2-methyl-1H-indol-5-yl ester
• Synonyms: 5-methyl-hexanoic acid 3-tert-butoxycarbonylmethyl-1-(4-chloro-benzoyl)-2-methyl-1H-indol-5-yl ester
• CAS NO: 1027849-38-2
• Molecular Weight: 512.046
• Mol File: 1027849-38-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 5-methyl-hexanoic acid 3-tert-butoxycarbonylmethyl-1-(4-chloro-benzoyl)-2-methyl-1H-indol-5-yl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-methyl-hexanoic acid 3-tert-butoxycarbonylmethyl-1-(4-chloro-benzoyl)-2-methyl-1H-indol-5-yl ester(1027849-38-2)
• EPA Substance Registry System: 5-methyl-hexanoic acid 3-tert-butoxycarbonylmethyl-1-(4-chloro-benzoyl)-2-methyl-1H-indol-5-yl ester(1027849-38-2)

Safety Data

• Hazardous Substances Data: 1027849-38-2(Hazardous Substances Data)

Upstream product

• 346424-35-9 t-butyl 5-benzyloxy-2-methyl indole acetate 
• 628-46-6 5-methylhexanoic acid 
• 346424-36-0 [1-(4-chloro-benzoyl)-5-hydroxy-2-methyl-1H-indol-3-yl]-acetic acid tert-butyl ester 
• 2854-10-6 levulinic acid t-butyl ester 
• 52068-30-1 4-benzyloxyphenylhydrazine hydrochloride 

Relevant articles and documents

Discovery of novel aldose reductase inhibitors using a protein structure-based approach: 3D-database search followed by design and synthesis

Aldose reductase (AR) has been implicated in the etiology of diabetic complications. Due to the limited number of currently available drugs for the treatment of diabetic complications, we have carried out structure-based drug design and synthesis in an at